Josef’s positive outlook
DATE: Tuesday 11th January 2022
Author:
Medlab,
When prostate cancer spreads, it most frequently goes to the bones and this is what happened in Josef’s case.
Josef, a former entrepreneur in the hospitality industry, from South Australia, was 66 years old when he first received the news – his prostate cancer had spread to his hip and rib. While managing to keep mentally positive about his diagnosis, he experienced considerable pain and discomfort. As time passed, Josef found it increasingly hard to complete daily tasks or do the things he loved. The pain often left him housebound and disrupted his sleep, leaving him feeling exhausted during the day.
Josef persevered, but managing his pain was becoming a problem – particularly as he did not want to start taking opioids – so he began to explore other pain relief options available to him.
After talking over his concerns with his specialist, Josef was enrolled in a Medlab Clinical observational study, which investigated the safety and further efficacy of a NanoCelle® medicinal cannabis medication (NanoCelle® 1:1 THC 8.93mg/ml and CBD 8.93mg/ml) in an oro-buccal spray. After completing the trial – with reduced pain and improved sleep – Josef’s outlook on life also improved as he was able leave the house, exercise, and do chores.
Disclaimers
All patient stories are based on real-life experiences as told to us, Josef has given consent to share his story and the photo is a real image of him. Josef is not affiliated with Medlab Clinical, received no payment as part of the study, but did receive the investigative drug at a subsidised price for the length of the observational study.
If you have prostate cancer or chronic pain and you are concerned about managing your pain or other symptoms, talk with your doctor about the treatment options available to you.
About the author
Medlab
Medlab in-house Editor.
11-13 LORD ST, BOTANY
BUILDING A, UNIT A5 – A6, BOTANY QUARTER
NSW, 2019, AUSTRALIA
www.medlab.co
OFFICE HOURS: 8:30AM - 5PM EST
AUS: 1300 369 570
AUS: +61 2 8188 0311
USA: +1 947 771 8119
UK: +44 20 8138 0311
FAX: +61 2 9699 3347
Email: [email protected]